Sheffield Hallam University
Kim Lawson received a BTech in pharmacology in 1981 from University of Bradford (UK) and a PhD in pharmacology in 1986 from the University of Sunderland (UK) and has an international reputation in Drug Discovery Research, gained in multinational pharmaceutical industries (France: Rhone-Poulenc Sante, Recherche Syntex France; Belgium: Sanofi-Labaz; UK: Reckitt & Colman, British Biotech) and academia. His research interests are focused on the pharmacology of potassium channels and to the identification of treatments of fibromyalgia. Kim is regularly invited as a consultant to the pharmaceutical and healthcare industries & affiliated organizations, to talk at public events & scientific conferences and to write 'expert opinion' articles for scientific and clinical journals. He is a member of Advisory Boards to the Fibromyalgia Association UK and FibroAction, in addition to being a Patron to Folly Pogs Fibromyalgia Research UK.
Dr Kim Lawson is a research pharmacologist with an international reputation in Drug Discovery Research. He has broad research experience gained in both academia and in multinational pharmaceutical industries.